Login / Signup

Improved Factor Combination for In Vivo Reprogramming of Cardiac Myofibroblast to Cardiomyocyte-Like Cell With Dual Recombinase Tracing.

Jingdong WuHong ZhaoYanmeng TaoChunyan YangYang YangBin ZhouYang Zhao
Published in: Circulation (2023)
Keyphrases
  • single cell
  • cell therapy
  • left ventricular
  • angiotensin ii
  • pulmonary fibrosis
  • signaling pathway